| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Zhiguo Miao | Q90151772 |
| P2093 | author name string | Yimin Wang | |
| Shan Wang | |||
| Jinzhou Zhang | |||
| Qiyuan Yang | |||
| P2860 | cites work | Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? | Q26750318 |
| The roles of mesenchymal stem cells in tumor inflammatory microenvironment | Q26823759 | ||
| Mesenchymal stem cells migration homing and tracking | Q27003059 | ||
| Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma | Q27309626 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Genetically modified mesenchymal stromal cells in cancer therapy | Q28071840 | ||
| Role of cancer microenvironment in metastasis: focus on colon cancer | Q28239062 | ||
| Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT | Q28543093 | ||
| Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion | Q29547317 | ||
| Multilineage cells from human adipose tissue: implications for cell-based therapies | Q29547688 | ||
| Mesenchymal stem cells reside in virtually all post-natal organs and tissues | Q29617740 | ||
| Pluripotency of mesenchymal stem cells derived from adult marrow | Q29617959 | ||
| Marrow stromal cells as stem cells for nonhematopoietic tissues | Q29618770 | ||
| TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo | Q30318545 | ||
| CDH1 and IL1-beta expression dictates FAK and MAPKK-dependent cross-talk between cancer cells and human mesenchymal stem cells. | Q30660784 | ||
| Stem cell origin of cancer and differentiation therapy | Q33203952 | ||
| iPS-derived MSCs from an expandable bank to deliver a prodrug-converting enzyme that limits growth and metastases of human breast cancers | Q33458985 | ||
| Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact | Q33595542 | ||
| Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging | Q34162598 | ||
| Fibroblasts in the Tumor Microenvironment: Shield or Spear? | Q55324986 | ||
| Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target? | Q55471455 | ||
| Corrigendum: Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression | Q57492340 | ||
| Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals | Q62083511 | ||
| Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors | Q64378688 | ||
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 | ||
| Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1 | Q73551297 | ||
| Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture | Q78800357 | ||
| Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells | Q80077858 | ||
| Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3 | Q80292406 | ||
| High frequency of early colorectal cancer in inflammatory bowel disease | Q80862185 | ||
| Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors | Q81411101 | ||
| Monitoring transplanted adipose tissue-derived stem cells combined with heparin in the liver by fluorescence imaging using quantum dots | Q83111529 | ||
| Mesenchymal stem cells enhance growth and metastasis of colon cancer | Q84233035 | ||
| Concise Review: Crosstalk of Mesenchymal Stroma/Stem-Like Cells with Cancer Cells Provides Therapeutic Potential | Q88232407 | ||
| MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells | Q88597093 | ||
| Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. | Q34164197 | ||
| The tumor microenvironment in colorectal carcinogenesis | Q34343645 | ||
| Fibroblast precursors in normal and irradiated mouse hematopoietic organs | Q34474362 | ||
| IL-6 secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells | Q34566168 | ||
| Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth | Q34741694 | ||
| The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents. | Q34992255 | ||
| The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity | Q35073652 | ||
| Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells | Q35082888 | ||
| Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer | Q35107504 | ||
| Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer | Q35552290 | ||
| Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model | Q35701638 | ||
| Inflammation, Innate Immunity, and the Intestinal Stromal Cell Niche: Opportunities and Challenges | Q35754092 | ||
| Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation | Q35803526 | ||
| Mesenchymal stem cells engineered for cancer therapy | Q36092724 | ||
| Immunomodulatory properties of mesenchymal stromal cells | Q36896799 | ||
| Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles | Q36901346 | ||
| Mesenchymal stem cells: revisiting history, concepts, and assays. | Q37036368 | ||
| Mesenchymal stem cells: an emerging tool for cancer targeting and therapy | Q37066661 | ||
| Immunogenicity of allogeneic mesenchymal stem cells. | Q37294916 | ||
| Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells. | Q37401479 | ||
| Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. | Q37407113 | ||
| Mesenchymal stem cell homing: the devil is in the details | Q37407769 | ||
| How Do Mesenchymal Stem Cells Influence or Are Influenced by Microenvironment through Extracellular Vesicles Communication? | Q37627116 | ||
| Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? | Q37645095 | ||
| The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research | Q37758303 | ||
| Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI. | Q37880662 | ||
| Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles | Q38024632 | ||
| What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer? | Q38219863 | ||
| Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors | Q38224550 | ||
| Organ-specific migration of mesenchymal stromal cells: Who, when, where and why? | Q38549653 | ||
| Immunological hallmarks of stromal cells in the tumour microenvironment | Q38608340 | ||
| TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy | Q38888391 | ||
| Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene | Q38903051 | ||
| Global patterns and trends in colorectal cancer incidence and mortality. | Q38915351 | ||
| Direct contacts with colon cancer cells regulate the differentiation of bone marrow mesenchymal stem cells into tumor associated fibroblasts | Q38971653 | ||
| Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. | Q38978972 | ||
| Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis | Q39009516 | ||
| Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer | Q39010568 | ||
| Impact of mesenchymal stem cell secreted PAI-1 on colon cancer cell migration and proliferation | Q39150245 | ||
| Mesenchymal stem cells promote growth and angiogenesis of tumors in mice | Q39255668 | ||
| Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells | Q39333106 | ||
| Mesenchymal stem cells: A new platform for targeting suicide genes in cancer. | Q39432344 | ||
| Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo | Q39569597 | ||
| Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. | Q39840843 | ||
| Induced pluripotent stem cell technology in regenerative medicine and biology | Q39863743 | ||
| Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells | Q39976240 | ||
| Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity | Q40080450 | ||
| Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy | Q40110233 | ||
| MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. | Q40188347 | ||
| Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells | Q40217732 | ||
| Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo | Q40363908 | ||
| Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway | Q41082417 | ||
| Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer | Q41691710 | ||
| Senescent mesenchymal stem cells promote colorectal cancer cells growth via galectin-3 expression | Q42513473 | ||
| Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy | Q42663878 | ||
| Protein kinase C zeta regulates interleukin-8-mediated stromal-derived factor-1 expression and migration of human mesenchymal stromal cells | Q43234499 | ||
| The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. | Q43599448 | ||
| Matrix cells from Wharton's jelly form neurons and glia | Q44279364 | ||
| Homing properties of mesenchymal stromal cells. | Q44919964 | ||
| Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells | Q45866586 | ||
| Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. | Q45870174 | ||
| Mesenchymal stem cell homing capacity | Q47857529 | ||
| Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer. | Q50075766 | ||
| Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. | Q50737303 | ||
| Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhibit liver metastasis in nude mice. | Q51001958 | ||
| Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. | Q51629480 | ||
| Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach. | Q52574713 | ||
| Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging. | Q52628020 | ||
| Bone marrow mesenchymal stem cells ameliorate colitis-associated tumorigenesis in mice. | Q54199350 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastroenterology | Q120569 |
| mesenchymal stem cell | Q1922379 | ||
| colonic neoplasm | Q3542029 | ||
| colon cancer | Q18555025 | ||
| cell | Q7868 | ||
| P304 | page(s) | 7628763 | |
| P577 | publication date | 2018-11-07 | |
| P1433 | published in | Canadian Journal of Gastroenterology & Hepatology | Q5030241 |
| P1476 | title | The Dynamic Roles of Mesenchymal Stem Cells in Colon Cancer | |
| P478 | volume | 2018 |
| Q90168903 | Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration |
| Q94570952 | Microphysiological Engineering of Immune Responses in Intestinal Inflammation |
| Q91637582 | The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer |
Search more.